Form 4 for ELVN Enliven Therapeutics, Inc.

Accepted 2022-02-14 00:00:00 ET · period of report 2022-02-10 · accession 0001209191-22-009391 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2022-02-14	2022-02-10+	ELVN	MOTT DAVID M	Dir	P - Purchase	$1.23	+31.8K	31.8K	New	+$39.2K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-02-10	P	A	8,753	$1.29	8,753	D	—	—	(F1) Open market purchases reported on this line occurred at a weighted average price of $1.29 (range $1.26 to $1.33). (F2) Mr. Mott undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.
2	Common	Common Stock	2022-02-11	P	A	14,573	$1.23	23,326	D	—	—	(F2) Mr. Mott undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price. (F3) Open market purchases reported on this line occurred at a weighted average price of $1.23 (range $1.17 to $1.29).
3	Common	Common Stock	2022-02-14	P	A	8,500	$1.18	31,826	D	—	—	(F2) Mr. Mott undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price. (F4) Open market purchases reported on this line occurred at a weighted average price of $1.18 (range $1.15 to $1.20).